Contents 2 min read

Claim and source comparison

Ginkgo biloba: dementia prevention, cognitive symptoms and safety.

· Bounded source comparison; not a complete clinical review or independent medical endorsement.

Human randomized controlled trial

The GEM trial randomized 3069 people aged 75 or older to 120 mg of leaf extract twice daily or placebo. The extract did not reduce new dementia cases over a median follow-up of 6.1 years.

The trial tracked new diagnoses in older adults who did not have dementia. It did not measure treatment of existing dementia symptoms.

Source 2 · Abstract read

Systematic review / meta-analysis

The 2026 Cochrane review found probably little to no difference in cognition, overall clinical status or daily function at 6 months in mild cognitive impairment. In dementia, these measures may improve somewhat, with low-certainty evidence.

Dementia trials produced markedly different results. Few reported follow-up beyond 6 months.

Source 7 · Abstract read

Official safety summary

NIH NCCIH warns that ginkgo may raise bleeding risk in people taking anticoagulants such as warfarin. Dizziness, digestive symptoms and headache have been reported with leaf extracts. Fresh seeds are toxic.

This summary does not quantify bleeding risk for each product and medicine combination.

Source 6 · Official summary read

Our evidence and source methodology

Ginkgo Biloba: conceptual editorial illustration
Conceptual editorial artwork; not a research finding or evidence of clinical benefit in humans.

What is Ginkgo Biloba?

Ginkgo biloba is the world's oldest tree species, known as a "living fossil" and appearing approximately 250 million years ago. The leaves of this plant, which has been used in traditional medicine in China for thousands of years, are also the focus of modern neuroscience research.

Ginkgo biloba used for nootropic purposes is not the raw leaf, standardized leaf extract. The most commonly researched form EGb 761 It is standardized to contain 24% flavonoid glycosides and 6% terpenlactone.

Active Compounds and Mechanism of Action

Ginkgo leaf extract contains flavonoids and terpene lactones. Mechanisms proposed for these constituents do not establish cognitive benefit or increased cerebral blood flow in humans.

Clinical Evidence

The GEM trial randomized 3069 people aged 75 or older to 120 mg of leaf extract twice daily or placebo. The extract did not reduce new dementia cases over a median follow-up of 6.1 years.

The 2026 Cochrane review found probably little to no difference in cognition, overall clinical status or daily function at 6 months in mild cognitive impairment. In dementia, these measures may improve somewhat, with low-certainty evidence.

Dose information and research limits

Dose information and research limits

This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.

Safety and Side Effects

NIH NCCIH warns that ginkgo may raise bleeding risk in people taking anticoagulants such as warfarin. Dizziness, digestive symptoms and headache have been reported with leaf extracts. Fresh seeds are toxic.

NCCIH cautions that use during pregnancy may be unsafe. Little is known about safety during breastfeeding.

Sources

  1. Le Bars PL, et al. (1997). A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA, 278(16), 1327–1332. PubMed · PMID 9343463
  2. DeKosky ST, et al. (2008). Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA, 300(19), 2253–2262. PubMed · PMID 19017911
  3. Weinmann S, et al. (2010). Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatrics, 10, 14. PubMed · PMID 20236541
  4. Brondino N, et al. (2013). A systematic review and meta-analysis of Ginkgo biloba in neuropsychiatric disorders: from ancient tradition to modern-day medicine. Evidence-Based Complementary and Alternative Medicine, 2013, 915691. PubMed · PMID 23781271
  5. Tan MS, et al. (2015). Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. Journal of Alzheimer's Disease, 43(2), 589–603. PubMed · PMID 25114079
  6. NIH NCCIH. Ginkgo: Usefulness and Safety. https://www.nccih.nih.gov/health/ginkgo NIH NCCIH
  7. Wieland LS, et al. (2026). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, Issue 2, CD013661. PubMed · PMID 41641880

Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory

Frequently Asked Questions